| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Akero Therapeutics, Inc. | Senior VP, Commercial Strategy | Common Stock | 34.3K | $998K | $29.13 | Dec 16, 2024 | Direct |
| Akero Therapeutics, Inc. | Senior VP, Commercial Strategy | Stock Option (Right to Buy) | 52.1K | Dec 16, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| AKRO | Akero Therapeutics, Inc. | Dec 16, 2024 | 3 | -$29.1K | 4 | Dec 18, 2024 | Senior VP, Commercial Strategy |
| AKRO | Akero Therapeutics, Inc. | Dec 10, 2024 | 1 | -$28.5K | 4 | Dec 12, 2024 | Senior VP, Commercial Strategy |
| AKRO | Akero Therapeutics, Inc. | Jun 28, 2024 | 1 | $4.41K | 4 | Jul 2, 2024 | Senior VP, Commercial Strategy |
| AKRO | Akero Therapeutics, Inc. | Jun 11, 2024 | 1 | -$12.9K | 4 | Jun 13, 2024 | Senior VP, Commercial Strategy |
| AKRO | Akero Therapeutics, Inc. | Dec 8, 2023 | 2 | $0 | 4 | Dec 12, 2023 | Senior Vice President, Commercial Strategy |
| AKRO | Akero Therapeutics, Inc. | Jan 10, 2023 | 1 | $0 | 4 | Jan 11, 2023 | Senior Vice President, Commercial Strategy |
| AKRO | Akero Therapeutics, Inc. | Jan 10, 2023 | 0 | $0 | 3 | Jan 11, 2023 | Exhibit 24: Power of Attorney Senior Vice President, Commercial Strategy |